Marchantin A, a macrocyclic bisbibenzyl ether, isolated from the liverwort Marchantia polymorpha, inhibits protozoal growth in vitro

Phytomedicine

Volumn 19, Issue 13, 2012, Pages 1191-1195

  Jensen, Sophie ^a   Omarsdottir, Sesselja ^a   Bwalya, Angela Gono ^b   Nielsen, Morten Agertoug ^c   Tasdemir, Deniz ^b   Olafsdottir, Elin Soffia ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Malaria; Marchantia; Marchantin A; PfFAS II; Plasmodium; Protozoa

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIMALARIAL AGENT; ANTITRYPANOSOMAL AGENT; ETHER; MARCHANTIN A; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; FRACTIONATION; IC 50; IN VITRO STUDY; LEISHMANIA DONOVANI; LIVERWORT; MARCHANTIA POLYMORPHA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPROTOZOAL AGENTS; BIBENZYLS; CELL LINE; ENZYME INHIBITORS; ETHERS, CYCLIC; MARCHANTIA; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; RATS; TOXICITY TESTS;

LEISHMANIA DONOVANI; MARCHANTIA; MARCHANTIA POLYMORPHA; PLASMODIUM FALCIPARUM; PROTOZOA; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 84866729527     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.07.011     Document Type: Article

References (34)

1. Y. Asakawa Recent advances in phytochemistry of bryophytes-acetogenins, terpenoids and bis(bibenzyl)s from selected Japanese, Taiwanese, New Zealand, Argentinean and European liverworts Phytochemistry 56 2001 297 312 (Pubitemid 32162800)
2. Y. Asakawa, A. Ludwiczuk, F. Nagashima, M. Toyota, T. Hashimoto, M. Tori, Y. Fukuyama, and L. Harinantenaina Bryophytes: bio- and chemical diversity, bioactivity and chemosystematics Heterocycles 77 2009 99 150
3. Y. Asakawa, M. Toyota, R. Matsuda, K. Takikawa, and T. Takemoto Distribution of novel cyclic bisbibenzyls in Marchantia and Riccardia species Phytochemistry 22 1983 1413 1415
4. Y. Asakawa, M. Toyota, M. Tori, and T. Hashimoto Chemical structures of macrocyclic bis(bibenzyls) isolated from liverworts (Hepaticae) International Journal of Spectroscopy 14 2000 149
5. F. Astelbauer, and J. Walochnik Antiprotozoal compounds: state of the art and new developments International Journal of Antimicrobial Agents 38 2011 118 124
6. J. Bero, and J. Quetin-Leclercq Natural products and tropical diseases Planta Medica 77 2011 571
7. D. Desta, R. Sjoholm, L. Lee, M. Lee, K. Dittenhafer, S. Canche, B. Babu, S. Chavda, C. Dewar, S. Yanow, A. Best, and M. Lee Synthesis and antiprotozoal activity of 1,2,3,4-tetrahydro-2-thioxopyrimidine analogs of combretastatin A-4 Medicinal Chemistry Research 20 2011 364 369
8. L.M. Fidalgo, and L. Gille Mitochondria and trypanosomatids: targets and drugs Pharmaceutical Research 28 2011 2758 2770
9. J. Gao, X. Li, B.-B. Lv, B. Sun, C.-J. Zhu, and H.-X. Lou LC-DAD/MS/MS detection of macrocyclic bisbibenzyls from the liverwort Reboulia hemisphaerica and the cell-based screening of their microtubule inhibitory effects Chinese Journal of Natural Medicines 7 2009 123 128
10. W.J. Huang, C.L. Wu, C.W. Lin, L.L. Chi, P.Y. Chen, C.J. Chiu, C.Y. Huang, and C.N. Chen Marchantin A, a cyclic bis(bibenzyl ether), isolated from the liverwort Marchantia emarginata subsp. tosana induces apoptosis in human MCF-7 breast cancer cells Cancer Letters 291 2010 108 119
11. Y. Iwai, K. Murakami, Y. Gomi, T. Hashimoto, Y. Asakawa, Y. Okuno, T. Ishikawa, D. Hatakeyama, N. Echigo, and T. Kuzuhara Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts PLoS One 6 2011 11
12. J.S.R.E. Jensen, S. Omarsdottir, J.B. Thorsteinsdottir, H.M. Ogmundsdottir, and E.S. Olafsdottir Synergistic cytotoxic effect of the microtubule inhibitor marchantin A from Marchantia polymorpha and the Aurora kinase inhibitor MLN8237 on breast cancer cells in vitro Planta Medica 2012
13. B. Johannsson Íslenskir mosar E. Olafsson, Refilmosabálkur og Stjörnumosabálkur 2002 The Icelandic Institute of Natural History Reykjavik 51 54
14. P.M. Kaye, and T. Aebischer Visceral leishmaniasis: immunology and prospects for a vaccine Clinical Microbiology and Infection 17 2011 1462 1470
15. G.M. Keser, and M. Nogradi The chemistry of macrocyclic bis(bibenzyls) Natural Products Reports 12 1995 69 75
16. M. Kodama, Y. Shiobara, H. Sumitomo, K. Matsumura, M. Tsukamoto, and C. Harada Total syntheses of marchantin A and riccardin B, cytotoxic bis(bibenzyls) from liverworts Journal of Organic Chemistry 53 1988 72 77 (Pubitemid 18030572)
17. D. Kostrewa, F.K. Winkler, G. Folkers, L. Scapozza, and R. Perozzo The crystal structure of PfFabZ, the unique beta-hydroxyacyl-ACP dehydratase involved in fatty acid biosynthesis of Plasmodium falciparum Protein Science 14 2005 1570 1580 (Pubitemid 41014815)
18. J.W.H. Li, and J.C. Vederas Drug discovery and natural products: end of an era or an endless frontier? Science 325 2009 161 165
19. K. Maity, B.S. Venkata, N. Kapoor, N. Surolia, A. Surolia, and K. Suguna Structural basis for the functional and inhibitory mechanisms of β-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Plasmodium falciparum Journal of Structural Biology 176 2011 238 249
20. Y. Min, T.R.S. Kumar, L.J. Nkrumah, A. Coppi, S. Retzlaff, C.D. Li, B.J. Kelly, P.A. Moura, V. Lakshmanan, J.S. Freundlich, J.C. Valderramos, C. Vilcheze, M. Siedner, J.H.C. Tsai, B. Falkard, A.B.S. Sidhu, L.A. Purcell, P. Gratraud, L. Kremer, A.P. Waters, G. Schiehser, D.P. Jacobus, C.J. Janse, A. Ager, W.R. Jacobs, J.C. Sacchettini, V. Heussler, P. Sinni, and D.A. Fidock The fatty acid biosynthesis enzyme Fabl plays a key role in the development of liver-stage malarial parasites Cell Host & Microbe 4 2008 567 578 (Pubitemid 352762958)
21. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the 30 years from 1981 to 2010 Journal of Natural Products 75 2012 311 335
22. K. Otoguro, A. Ishiyama, M. Iwatsuki, M. Namatame, A. Nishihara-Tukashima, H. Kiyohara, T. Hashimoto, Y. Asakawa, S. Ōmura, and H. Yamada In vitro antitrypanosomal activity of bis(bibenzyls)s and bibenzyls from liverworts against Trypanosoma brucei Journal of Natural Medicines 2011 1 6
23. 2+ ionophore A23187 stimulated human granulocytes Phytomedicine 2 1996 309 311
24. B. Pradines, S. Alibert-Franco, C. Houdoin, J. Mosnier, C. Santelli-Rouvier, V. Papa, C. Rogier, T. Fusai, J. Barbe, and D. Parzy In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives American Journal of Tropical Medicine and Hygiene 66 2002 661 666 (Pubitemid 35001036)
25. D. Saxena, and H. Harinder Uses of bryophytes Resonance 9 2004 56 65
26. F. Scala, E. Fattorusso, M. Menna, O. Taglialatela-Scafati, M. Tierney, M. Kaiser, and D. Tasdemir Bromopyrrole alkaloids as lead compounds against protozoan parasites Marine Drugs 8 2010 2162 2174
27. C. Schwartner, W. Bors, C. Michel, U. Franck, B. MullerJakic, A. Nenninger, Y. Asakawa, and H. Wagner Effect of Marchantins and related compounds on 5-lipoxygenase and cyclooxygenase and their antioxidant properties: a structure activity relationship study Phytomedicine 2 1995 113 117
28. Y. Shi, C. Zhu, H. Yuan, B. Li, J. Gao, X. Qu, B. Sun, Y. Cheng, S. Li, X. Li, and H. Lou Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro Cancer Letters 276 2009 160 170
29. D. Tasdemir, M. Kaiser, R. Brun, V. Yardley, T.J. Schmidt, F. Tosun, and P. Ruedi Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies Antimicrobial Agents and Chemotherapy 50 2006 1352 1364
30. D. Tasdemir, G. Lack, R. Brun, P. Ruedi, L. Scapozza, and R. Perozzo Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids Journal of Medicinal Chemistry 49 2006 3345 3353 (Pubitemid 43830532)
31. The RTS, Clinical Trials Partnership, 2011. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. New England Journal of Medicine 365, 1863-1875.
32. A.M. Vaughan, M.T. O'Neill, A.S. Tarun, N. Camargo, T.M. Phuong, A.S.I. Aly, A.F. Cowman, and S.H.I. Kappe Type II fatty acid synthesis is essential only for malaria parasite late liver stage development Cellular Microbiology 11 2009 506 520
33. H.L. Ziegler, D. Staerk, J. Christensen, L. Hviid, H. Hagerstrand, and J.W. Jaroszewski In vitro Plasmodium falciparum drug sensitivity assay: inhibition of parasite growth by incorporation of stomatocytogenic amphiphiles into the erythrocyte membrane Antimicrobial Agents and Chemotherapy 46 2002 1441 1446 (Pubitemid 34415326)
34. V.K. Zishiri, R. Hunter, P.J. Smith, D. Taylor, R. Summers, K. Kirk, R.E. Martin, and T.J. Egan A series of structurally simple chloroquine chemosensitizing dibemethin derivatives that inhibit chloroquine transport by PfCRT European Journal of Medical Chemistry 46 2011 1729 1742